申请人:ADIR, s.a.r.l.
公开号:US04567169A1
公开(公告)日:1986-01-28
New nitrosourea compounds that can be used as medicaments and correspond to the general formula I ##STR1## in which R.sub.1 is hydrogen, C.sub.1 -C.sub.6 alkyl or phenyl, R.sub.2 is hydrogen, C.sub.1 -C.sub.6 alkyl, thienyl, or phenyl which may carry substituents, R.sub.3 is hydrogen, C.sub.1 -C.sub.6 alkyl, or benzyl which may carry substituents, or R.sub.2 and R.sub.3 together represent --(CH.sub.2).sub.m --, m being 3 or 4. Pharmaceutical compositions; therapeutic administration especially for the treatment of tumours.
可以用作药物的新硝基脲化合物,其符合一般式I## STR1##其中R.sub.1是氢,C.sub.1-C.sub.6烷基或苯基,R.sub.2是氢,C.sub.1-C.sub.6烷基,噻吩基或苯基,可以携带取代基,R.sub.3是氢,C.sub.1-C.sub.6烷基或苄基,可以携带取代基,或R.sub.2和R.sub.3一起表示--(CH.sub.2).sub.m--,其中m为3或4。药物组合物;治疗管理,特别是用于肿瘤的治疗。